Data / Form D filings / NextEvo, Inc.
NextEvo, Inc.: Form D filings
NextEvo, Inc., a pharmaceuticals company in Conshohocken, PA, filed 5 Form D notices with the SEC between 2025 and 2026. The latest, on April 29, 2026, reports $725,000 sold of an offering with no set size to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 181 WASHINGTON STREET SUITE 450, Conshohocken, PA, 19428
- Phone
- (925) 200-6766
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2053885
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | Amendment | Indefinite | $725,000 | 1 | Jan 13, 2025 | sec.gov | |
| Feb 17, 2026 | Amendment | Indefinite | $600,000 | 1 | Jan 13, 2025 | sec.gov | |
| Dec 17, 2025 | Amendment | Indefinite | $500,000 | 1 | Jan 13, 2025 | sec.gov | |
| Mar 17, 2025 | Amendment | $300,000 | $300,000 | 1 | Jan 13, 2025 | sec.gov | |
| Jan 29, 2025 | New notice | $100,000 | $100,000 | 1 | Jan 13, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Howard Goodwin | Executive Officer, Director | Chief Executive Officer and Director |
| Gerry McNally | Executive Officer | Vice President of Research and Development |
| Cornelius Merlini | Director | |
| Gerald Stahlecker | Executive Officer, Director | Secretary and Director |
| Ross Desmarais | Executive Officer, Director | Treasurer and Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
- PLEOPHARMA, INC. $5.5 million · Aug 10, 2026
- Duo Oncology Inc. $1.6 million · Aug 7, 2026
Every Form D from the week of Apr 27, 2026 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what NextEvo, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.